Page 241 - Pagetit
P. 241

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE




                   Informed consent
                   Informed consent to participate in a research study is usually a matter of
                   asking the research participant to consent to their participation after a
                   detailed discussion of what it will entail and a description of any adverse
                   events that may occur (Brody, 1998). The participation of persons under the
                   age of 18 years would normally require the consent of a parent or guardian,
                   along with the assent of the participant. Any uncertainty about the risks of
                   participation must be accurately communicated and there must be close
                   monitoring of any adverse events, with medical care promptly provided for
                   any adverse outcomes. The inclusion of persons with cognitive impairments
                   in a study may require special consideration (see below). Consent may need
                   to be obtained from a surrogate who makes a decision on behalf of the
                   impaired research participant (Brody, 1998). This has implications for research
                   involving persons with substance dependence if the person has long-term
                   cognitive, psychiatric, or neurological dysfunction as a result of substance
                   use (see Chapter 4), or if the person has a concurrent psychiatric illness (see
                   Chapter 6).
                     All forms of consent must be given after the participants are informed of
                   what their involvement in the research will require of them. Research
                   participants should have time to reflect on and consider their obligations at
                   each stage of the consent procedure. Ideally, the consent process should
                   include a third party, usually a clinician not involved in the study, to ensure
                   the integrity of the process. Participants must be allowed to withdraw from
                   the study at any time. If they decide to withdraw, their decision must be
                   respected and they must be informed that they will not suffer any
                   consequences, such as refusal of routine counselling or medical care (Brody,
                   1998). If any participant withdraws from the study, the data collected from
                   them must be omitted from the final results.


                   Recruitment of subjects
                   The conditions under which persons are recruited into a study must not
                   involve any form of coercion or the use of excessive inducements to
                   participate (Brody, 1998). In recent years, it has become common to reimburse
                   participants for their involvement in some research studies. The most
                   common justification is that reimbursements maximize initial recruitment
                   and retention of participants in a study. Small reimbursements are offered to
                   compensate participants for the time spent participating in a trial or for their
                   travel expenses. Reimbursements may be interpreted by some potential
                   subjects as rewards for participation, and by researchers as a way of increasing
                   the number of trial participants. Ashcroft argues that inducements are
                   ethically acceptable if the inducement serves to recompense a participant
                   for the inconvenience, as long as it is not seen as a payment for any harm
                   caused (Ashcroft, 2001). In Australia, for example, it has been common


                                                  220




          Chapter_7                220                             19.1.2004, 11:50
   236   237   238   239   240   241   242   243   244   245   246